scholarly journals Immediate results of mitral valve-in-valve implantation for bioprosthetic valve dysfunction

2015 ◽  
Vol 19 (2) ◽  
pp. 36 ◽  
Author(s):  
L. S. Barbarash ◽  
A. N. Stasev ◽  
S. G. Kokorin ◽  
N. V. Rutkovskaya ◽  
I. N. Sizova

<p><strong>Background</strong>. Patients with bioprosthetic valve dysfunction have a higher risk for redo procedures because of advanced age, comorbidities and redo-related technical difficulties. Thus, valve-in-valve replacement seems to be an easier and safer option for this group of patients.<br />Objective. To assess the immediate results of mitral valve-in-valve implantation for bioprosthetic valve dysfunction.<br /><strong>Methods</strong>. 6 patients underwent mitral valve-in-valve implantation using “UniLine” prostheses at Kemerovo Research Institute for Complex Problems of Cardiovascular Diseases in 2014.<br /><strong>Results.</strong> There were no cases of in-hospital deaths and prosthesis-related complications in the group under study. Satisfactory performance of bioprostheses was confirmed by echocardiography offered to all the patients before their discharge. <br /><strong>Conclusion.</strong> Mitral valve-in-valve implantation for bioprosthetic valve dysfunction allows achieving satisfactory immediate results.</p>

2013 ◽  
Vol 61 (17) ◽  
pp. 1759-1766 ◽  
Author(s):  
Anson Cheung ◽  
John G. Webb ◽  
Marco Barbanti ◽  
Melanie Freeman ◽  
Ronald K. Binder ◽  
...  

2013 ◽  
Vol 61 (10) ◽  
pp. E1750
Author(s):  
Marco Barbanti ◽  
John Webb ◽  
Freeman Melanie ◽  
Ronald Binder ◽  
Christopher Thompson ◽  
...  

2018 ◽  
Vol 93 (6) ◽  
pp. 1087-1094 ◽  
Author(s):  
Timothy A. Joseph ◽  
Mackram F. Eleid ◽  
Allison K. Cabalka ◽  
Joseph F. Maalouf ◽  
Charanjit S. Rihal

2019 ◽  
Vol 87 (5) ◽  
pp. 380-382
Author(s):  
Juan R. Alderete ◽  
Alberto C. Anaya Revolledo ◽  
Verónica I. Volberg ◽  
Miguel Rubio ◽  
Gustavo E. Barrera ◽  
...  

2016 ◽  
Vol 22 (4) ◽  
pp. 501-503 ◽  
Author(s):  
Isabel Baldizon ◽  
Andres Espinoza ◽  
Thomas Kuntze ◽  
Evaldas Girdauskas

Author(s):  
Adeline Fuchs ◽  
Marina Urena ◽  
Caroline Chong-Nguyen ◽  
John Kikoïne ◽  
Eric Brochet ◽  
...  

Background: Transcatheter mitral valve implantation (TMVI) is emerging as an alternative to surgical mitral valve replacement in selected high-risk patients. Delaying definitive mechanical mitral valve replacement and the constraints of anticoagulation thanks to TMVI may be an attractive option in young women contemplating pregnancy and suffering from failure of mitral bioprosthesis or annuloplasty. The aim of the study was to evaluate the possibility, safety, and outcomes of pregnancy after TMVI in this population. Methods: From 2013 to 2019, 12 young women contemplating pregnancy underwent transseptal valve-in-valve or valve-in-ring TMVI using the Edwards SAPIEN XT/3 valves and were prospectively followed up at 1 month, 6 months, 1 year, and yearly thereafter. Results: Mean age of the patients was 30±6 years. Bioprosthesis degeneration was observed in 7 cases and annuloplasty failure in 5. Three valve-in-ring patients required the implantation of a second valve, which led to an overall procedural success rate of 75%. One delayed left ventricular outflow tract obstruction required elective surgical mitral valve replacement. At 6 months/1 year, 83% of the patients were in New York Heart Association classes I/II. Mitral regurgitation was ≤2+ in all the cases and mean gradient was 7±2 mm Hg. Four patients could complete 6 full-term pregnancies. One symptomatic thrombosis occurred and resolved under aspirin and anticoagulation therapy. All others pregnancies were uneventful. Predelivery mean gradient was 11 mm Hg, and systolic pulmonary artery pressure was 32 mm Hg. There were 4 vaginal deliveries and 2 cesarians. Newborns were alive and healthy. At last follow-up, there was no death, and 3 patients required elective surgical mitral valve replacement at 6- to 54-month follow-up. Conclusions: Our study suggests that, in young women, transseptal TMVI to treat failing bioprostheses may result in good short-term outcomes that allow uneventful pregnancies. The results are less favorable in women with failed annuloplasty rings.


Author(s):  
Riccardo Cocchieri ◽  
Ezra Y. Koh ◽  
Bas A. De Mol

We report a case of transapical mitral valve-in-valve implantation for a deteriorated bioprosthesis using the SAPIEN 3. Our patient, a 79-year-old man, with a history of mitral valve replacement 10 years before, presented with acute dyspnea due to mitral valve dysfunction. He was successfully treated with transapical implantation and had an uneventful recovery. Our case demonstrates the feasibility of using SAPIEN 3 in treating degenerated bioprosthetic mitral valves.


Sign in / Sign up

Export Citation Format

Share Document